Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5

12Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Hermansky-Pudlak syndrome (HPS) is a heterogeneous group of genetic disorders typically manifesting with tyrosinase-positive oculocutaneous albinism, bleeding diathesis, and pulmonary fibrosis, in some subtypes. Most HPS subtypes are associated with defects in Biogenesis of Lysosome-related Organelle Complexes (BLOCs), which are groups of proteins that function together in the formation and/or trafficking of lysosomal-related endosomal compartments. BLOC-2, for example, consists of the proteins HPS3, HPS5, and HPS6. Here we present an HPS patient with defective BLOC-2 due to a novel intronic mutation in HPS5 that activates a cryptic acceptor splice site. This mutation leads to the insertion of nine nucleotides in-frame and results in a reduced amount of HPS5 at the transcript and protein level. In studies using skin fibroblasts derived from the proband and two other individuals with HPS-5, we found a perinuclear distribution of acidified organelles in patient cells compared to controls. Our results suggest the role of HPS5 in the endo-lysosomal dynamics of skin fibroblasts.

Cite

CITATION STYLE

APA

Stephen, J., Yokoyama, T., Tolman, N. J., O’Brien, K. J., Nicoli, E. R., Brooks, B. P., … Malicdan, M. C. V. (2017). Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5. PLoS ONE, 12(3). https://doi.org/10.1371/journal.pone.0173682

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free